PPD Inc (PPD) Stock Price & Overview
NASDAQ:PPD
Current stock price
The current stock price of PPD is 47.28 null. Today PPD is down by -0.06%. In the past month the price increased by 0.06%. In the past year, price increased by 37.36%.
PPD Key Statistics
- Market Cap
- 16.999B
- P/E
- 30.31
- Fwd P/E
- 25.69
- EPS (TTM)
- 1.56
- Dividend Yield
- N/A
PPD Stock Performance
PPD Stock Chart
PPD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PPD. When comparing the yearly performance of all stocks, PPD is one of the better performing stocks in the market, outperforming 82.3% of all stocks.
PPD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PPD. PPD has an average financial health and profitability rating.
PPD Earnings
PPD Forecast & Estimates
17 analysts have analysed PPD and the average price target is 48.25 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 47.28.
For the next year, analysts expect an EPS growth of 37.26% and a revenue growth 31.13% for PPD
PPD Groups
Sector & Classification
PPD Financial Highlights
Over the last trailing twelve months PPD reported a non-GAAP Earnings per Share(EPS) of 1.56. The EPS increased by 39.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.19% | ||
| ROA | 5.18% | ||
| ROE | N/A | ||
| Debt/Equity | -9.91 |
PPD Ownership
PPD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.73 | 184.295B | ||
| DHR | DANAHER CORP | 23.06 | 134.187B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 138.13 | 45.413B | ||
| A | AGILENT TECHNOLOGIES INC | 17.49 | 32.516B | ||
| WAT | WATERS CORP | 22.33 | 31.392B | ||
| IQV | IQVIA HOLDINGS INC | 13.41 | 28.091B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 28.66 | 26.832B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 32.06 | 18.492B | ||
| ILMN | ILLUMINA INC | 24.26 | 18.49B | ||
| MEDP | MEDPACE HOLDINGS INC | 28.71 | 14.095B | ||
| RVTY | REVVITY INC | 16.83 | 10.039B | ||
| TECH | BIO-TECHNE CORP | 25.9 | 8.689B | ||
| CRL | CHARLES RIVER LABORATORIES | 16.01 | 8.667B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PPD
Company Profile
PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The company is headquartered in Wilmington, North Carolina and currently employs 26,000 full-time employees. The company went IPO on 2020-02-06. The firm provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The firm operates through two segments: Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides a range of services to its customers including early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment provides services to its customers including bioanalytical, vaccine sciences, good manufacturing practice (GMP), central lab and biomarker testing.
Company Info
IPO: 2020-02-06
PPD Inc
929 North Front Street
Wilmington NORTH CAROLINA 28401 US
CEO: David Simmons
Employees: 26000
Phone: 19102510081.0
PPD Inc / PPD FAQ
What does PPD Inc do?
PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The company is headquartered in Wilmington, North Carolina and currently employs 26,000 full-time employees. The company went IPO on 2020-02-06. The firm provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The firm operates through two segments: Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides a range of services to its customers including early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment provides services to its customers including bioanalytical, vaccine sciences, good manufacturing practice (GMP), central lab and biomarker testing.
Can you provide the latest stock price for PPD Inc?
The current stock price of PPD is 47.28 null. The price decreased by -0.06% in the last trading session.
Does PPD stock pay dividends?
PPD does not pay a dividend.
What is the ChartMill rating of PPD Inc stock?
PPD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is PPD stock listed?
PPD stock is listed on the Nasdaq exchange.
What is the market capitalization of PPD stock?
PPD Inc (PPD) has a market capitalization of 17.00B null. This makes PPD a Large Cap stock.
What is the ownership structure of PPD Inc (PPD)?
You can find the ownership structure of PPD Inc (PPD) on the Ownership tab.